These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18623608)

  • 41. Comparison of statistical methods for analysis of clustered binary observations.
    Heo M; Leon AC
    Stat Med; 2005 Mar; 24(6):911-23. PubMed ID: 15558576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple imputation by predictive mean matching in cluster-randomized trials.
    Bailey BE; Andridge R; Shoben AB
    BMC Med Res Methodol; 2020 Mar; 20(1):72. PubMed ID: 32228491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of treatment noncompliance on power in a 2 x 2 factorial design.
    Lindblad AS
    J Biopharm Stat; 1996 Jul; 6(3):263-70. PubMed ID: 8854231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials.
    Ukoumunne OC
    Stat Med; 2002 Dec; 21(24):3757-74. PubMed ID: 12483765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Weighting in instrumental variables and G-estimation.
    Joffe MM; Brensinger C
    Stat Med; 2003 Apr; 22(8):1285-303. PubMed ID: 12687655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The implications of non-compliance: Randomised controlled trials: the intention-to-treat principle.
    Platt AC; Turner EL
    BJOG; 2019 Oct; 126(11):1337. PubMed ID: 31222882
    [No Abstract]   [Full Text] [Related]  

  • 50. Methodological review showed that time-to-event outcomes are often inadequately handled in cluster randomized trials.
    Caille A; Tavernier E; Taljaard M; Desmée S
    J Clin Epidemiol; 2021 Jun; 134():125-137. PubMed ID: 33581243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lag-censoring analysis: lights and shades.
    Tripepi G; Heinze G; Jager KJ; Stel VS; Dekker FW; Zoccali C
    Nephrol Dial Transplant; 2015 May; 30(5):700-5. PubMed ID: 25883199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Practical properties of some structural mean analyses of the effect of compliance in randomized trials.
    Fischer-Lapp K; Goetghebeur E
    Control Clin Trials; 1999 Dec; 20(6):531-46. PubMed ID: 10588294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased risk of type I errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study.
    Kahan BC; Forbes G; Ali Y; Jairath V; Bremner S; Harhay MO; Hooper R; Wright N; Eldridge SM; Leyrat C
    Trials; 2016 Sep; 17(1):438. PubMed ID: 27600609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sample Size Estimates for Cluster-Randomized Trials in Hospital Infection Control and Antimicrobial Stewardship.
    Blanco N; Harris AD; Magder LS; Jernigan JA; Reddy SC; O'Hagan J; Hatfield KM; Pineles L; Perencevich E; O'Hara LM
    JAMA Netw Open; 2019 Oct; 2(10):e1912644. PubMed ID: 31584684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
    Cunanan KM; Carlin BP; Peterson KA
    Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.
    Nie H; Cheng J; Small DS
    Biometrics; 2011 Dec; 67(4):1397-405. PubMed ID: 21385167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised controlled trials (RCTs) in sports injury research: authors-please report the compliance with the intervention.
    Nielsen RO; Bertelsen ML; Ramskov D; Damsted C; Verhagen E; Bredeweg SW; Theisen D; Malisoux L
    Br J Sports Med; 2020 Jan; 54(1):51-57. PubMed ID: 31511232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A systematic review finds variable use of the intention-to-treat principle in musculoskeletal randomized controlled trials with missing data.
    Joseph R; Sim J; Ogollah R; Lewis M
    J Clin Epidemiol; 2015 Jan; 68(1):15-24. PubMed ID: 25304501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.